Trevena announces plans to price $40 million public offering of stock

Barclays, Cowen and Jefferies are bookrunners; JMP and Needham assist

By Devika Patel

Knoxville, Tenn., Nov. 20 – Trevena, Inc. will conduct a $40 million public sale of its common stock with a $6 million greenshoe, according to a Form S-1 filed Thursday with the Securities and Exchange Commission.

Barclays, Cowen and Co. and Jefferies are the bookrunning managers. JMP Securities and Needham & Co. are the co-managers.

Proceeds will be used for clinical development expenses, including clinical trials, development activities, preclinical research and development, working capital and general corporate purposes.

The clinical-stage biopharmaceutical company is based in King of Prussia, Pa.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.